Option Care Health jumps after $32.05-per-share buyout deal

Option Care Health (OPCH) is up 32.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears tied to a definitive agreement for Option Care Health to be acquired by an investor group led by CD&R and McKesson affiliates for $32.05 per share in cash. That kind of all-cash takeover typically pushes a stock quickly toward the offer price, especially when the bid represents a sizable premium to the prior close.

Details:

Option Care Health announced an agreement to be acquired for $32.05 a share in cash, implying a total enterprise value of about $5.8 billion.

The offer represented roughly a 37% premium to the company’s October 5 closing price, helping explain why the stock repriced so sharply higher.

The buyer group includes CD&R and McKesson affiliates, with CD&R set to hold the majority ownership stake and McKesson a minority stake at closing.

The transaction is expected to close in the first half of 2027, subject to shareholder approval and customary regulatory clearances, which helps explain why the shares traded below the cash offer price.

Sources:

Option Care Health investor relations, Associated Press, Axios

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$OPCH Insider Trading Activity

$OPCH insiders have traded $OPCH stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OPCH stock by insiders over the last 6 months:

HARRY M JANSEN JR KRAEMER purchased 36,610 shares for an estimated $783,772
TIMOTHY P SULLIVAN purchased 24,154 shares for an estimated $499,671
MEENAL SETHNA (Chief Financial Officer) purchased 16,225 shares for an estimated $327,074
JOHN CHARLES RADEMACHER (Chief Executive Officer) purchased 12,500 shares for an estimated $264,706

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$OPCH Hedge Fund Activity

We have seen 194 institutional investors add shares of $OPCH stock to their portfolio, and 192 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 4,606,988 shares (-71.7%) from their portfolio in Q2 2026, for an estimated $96,608,538
SOUTHPOINT CAPITAL ADVISORS LP removed 3,600,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $75,492,000
DURABLE CAPITAL PARTNERS LP removed 2,827,532 shares (-31.4%) from their portfolio in Q2 2026, for an estimated $59,293,346
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,464,334 shares (+inf%) to their portfolio in Q2 2026, for an estimated $51,677,083
BLACKROCK, INC. added 2,217,031 shares (+11.1%) to their portfolio in Q2 2026, for an estimated $46,491,140
DUQUESNE FAMILY OFFICE LLC removed 1,868,550 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $39,183,493
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,744,033 shares (+41.2%) to their portfolio in Q2 2026, for an estimated $36,572,372

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$OPCH Price Targets

Multiple analysts have issued price targets for $OPCH recently. We have seen 6 analysts offer price targets for $OPCH in the last 6 months, with a median target of $30.0.

Here are some recent targets:

Scott Fidel from Goldman Sachs set a target price of $22.0 on 06/08/2026
Erin Wright from Morgan Stanley set a target price of $28.0 on 05/06/2026
Lisa Gill from JP Morgan set a target price of $33.0 on 05/04/2026
Charles Rhyee from TD Cowen set a target price of $23.0 on 05/01/2026
A.J. Rice from UBS set a target price of $39.0 on 05/01/2026
Michael Petusky from Barrington Research set a target price of $32.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.